RN
ReNeuron Group plc
RNUGF · OTC
$0.00 +0.00% (+$0.00)
Market Cap £47.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.09x
P/B 0.01x
P/E N/A
Growth
0 /100
Declining Rev. growth 55.62%
Book val. growth 27.41%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 742.08%
Net margin 1,020.38%
Op. margin 1,342.45%
Quality
1 /100
Poor ROIC 105.51%
ROA 56.07%
Asset turnover 0.05x
Debt
69 /100
Low Debt/Equity 0.08x
Current ratio 2.05x
Int. coverage -331.85x
Stability
51 /100
Moderate Beta 1.04x
Rev. volatility 81.77%
EPS volatility 14.91%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na RNUGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Iain Gladstone Ross
Employees
26
Headquarters
Pencoed
Nadcházející události
11 LIS
Earnings
Upcoming earnings report